somone uk
Experienced Member
- Reaction score
- 6
From what i can tell, follica is dead, or dead quiet newish website.
Replicel has been bought buy big cosmetics, I'd argue this is bad news since a large company is more likely to pull the plug if they don't see a potential return (Like what happened to adreans), curing male pattern baldness is a risky investment and therefore quite a bad one when you look at the numbers. Even worse they could potentially sit on it as capital rather than sell it off in such a case.
and a hypothesis that pgd2 causes hairloss and DHT causes pgd2, good news if the model holds water, although the model claims that pgd2 is low in the nw8 area and high everywhere else, this model seems incompatible with the fact that hair transplants work since the model suggests that the moved hair should become loss when transplanted (ie moving from low pgd2 to high pgd2)
any new biotech i missed?.
Replicel has been bought buy big cosmetics, I'd argue this is bad news since a large company is more likely to pull the plug if they don't see a potential return (Like what happened to adreans), curing male pattern baldness is a risky investment and therefore quite a bad one when you look at the numbers. Even worse they could potentially sit on it as capital rather than sell it off in such a case.
and a hypothesis that pgd2 causes hairloss and DHT causes pgd2, good news if the model holds water, although the model claims that pgd2 is low in the nw8 area and high everywhere else, this model seems incompatible with the fact that hair transplants work since the model suggests that the moved hair should become loss when transplanted (ie moving from low pgd2 to high pgd2)
any new biotech i missed?.
